BOTHELL, Wash., June 4 /PRNewswire-FirstCall/ -- Cardiac Science Corporation (Nasdaq: CSCX), a global leader in advanced cardiac diagnosis, resuscitation, rehabilitation, and informatics products, announced it will present at the Eighth Annual Needham & Company Biotechnology and Medical Technology Conference at the New York Palace Hotel. Dave Marver, president and chief executive officer, will review the Company's business strategy and recent financial results during the Company's presentation on Thursday, June 11, 2009 at 10:30 a.m. Eastern Time.
Attendance at the conference is by invitation only. Cardiac Science will offer a live Web cast of its presentation, accessible at http://cardiacscience.com. An archived replay of the presentation will also be available following the live presentation at http://cardiacscience.com for 90 days.
About Cardiac Science
Cardiac Science develops, manufactures, and markets a family of advanced diagnostic and therapeutic cardiology devices and systems, including automated external defibrillators (AED), electrocardiograph devices (ECG/EKG), cardiac stress treadmill and systems, Holter monitoring systems, hospital defibrillators, cardiac rehabilitation telemetry systems, and cardiology data management systems (informatics) that connect with hospital information (HIS), electronic medical record (EMR), and other information systems. The company sells a variety of related products and consumables and provides a portfolio of training, maintenance, and support services. Cardiac Science, the successor to the cardiac businesses that established the trusted Burdick(R), HeartCentrix(R), Powerheart(R), and Quinton(R) brands, is headquartered in Bothell, Washington. With customers in more than 100 countries worldwide, the company has operations in North America, Europe, and Asia. For information, call 425.402.2000 or visit http://cardiacscience.com.
For updates and information about Cardiac Science and the industry, please subscribe to the Cardiac Science blog at http://cardiacscience.com/blog/ and follow us on Twitter at http://twitter.com/cardiacscience.
For more information,
Company Contact: Investor Contact: Media Contact: Mike Matysik Matt Clawson Christopher Gale Cardiac Science Corporation Allen & Caron EVC Group, Inc. Sr. Vice President and CFO 949.474.4300 201.646.5431 425.402.2009 firstname.lastname@example.org 203.570.4681 email@example.com
|SOURCE Cardiac Science Corporation|
Copyright©2009 PR Newswire.
All rights reserved